These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6482993)

  • 1. [Cardiotoxicity of doxorubicin in children].
    Pilon JW; Naeff MS; Taminiau JA
    Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Doxorubicin-induced cardiomyopathy].
    Czarnecki A
    Pol Tyg Lek; 1983 Apr; 38(15):471-3. PubMed ID: 6356084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adriamycin cardiomyopathy].
    Nilles M; Wehr M; Köhler F
    Med Welt; 1984 Jan; 35(4):103-8. PubMed ID: 6700420
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of the anthracycline derivative doxorubicin on myocardial function in children].
    Sobotka-Plojhar MA; Daniëls O; Rohmer J; Veerman AJ; Lippens R; van Lier H
    Ned Tijdschr Geneeskd; 1989 Jul; 133(27):1367-70. PubMed ID: 2797225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low R-wave amplitude in the right precordial leads in children with symptomatic doxorubicin cardiomyopathy.
    Umemoto M; Azuma E; Itoh M; Komada Y; Ido M; Kawasaki H; Kita H; Sakurai M
    Pediatr Cardiol; 1993 Mar; 14(2):107-9. PubMed ID: 8385775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cardiac failure from doxorubicin cardiotoxicity provoked in relation to second-look laparotomy.
    Aabo K; Mortensen SA; Jonsson T; Hansen HH
    Cancer Treat Rep; 1985 Jun; 69(6):730-1. PubMed ID: 4016780
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 8. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
    Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin (Adriamycin) cardiotoxicity.
    Weisburst MR; Pearlman ES; Capone RJ
    Conn Med; 1980 Mar; 44(3):133-6. PubMed ID: 7363615
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful long-term course after heart transplantation for anthracycline cardiomyopathy in a young boy despite neurological complications.
    Deng MC; Kececioglu D; Weyand M; Moskopp D; Fahrenkamp A; Wendt M; Scheld HH
    Thorac Cardiovasc Surg; 1994 Apr; 42(2):122-4. PubMed ID: 8016827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiomyopathy in the course of treating Hodgkin's disease in a 12-year old girl].
    Wójtowicz J; Hryniewicz A; Rosłan K
    Kardiol Pol; 1993 Jul; 39(7):27-30. PubMed ID: 7692125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related adriamycin cardiotoxicity in children.
    Pratt CB; Ransom JL; Evans WE
    Cancer Treat Rep; 1978 Sep; 62(9):1381-5. PubMed ID: 356987
    [No Abstract]   [Full Text] [Related]  

  • 13. Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
    Bai P; Mabley JG; Liaudet L; Virág L; Szabó C; Pacher P
    Oncol Rep; 2004 Feb; 11(2):505-8. PubMed ID: 14719091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma endothelin-1 and doxorubicin cardiotoxicity.
    Yamashita J; Ogawa M; Nomura K
    N Engl J Med; 1994 Dec; 331(22):1528-9. PubMed ID: 7969316
    [No Abstract]   [Full Text] [Related]  

  • 15. Amelioration of doxorubicin cardiotoxicity by the bispiperazinedione ICRF-187 in women with advanced breast cancer: a preliminary report.
    Jurga L; Misurová E; Vancík J
    Neoplasma; 1993; 40(4):259-62. PubMed ID: 8272153
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation.
    Casarotto D; Bottio T; Gambino A; Testolin L; Gerosa G
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):417-8. PubMed ID: 12579117
    [No Abstract]   [Full Text] [Related]  

  • 18. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
    Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
    Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and doxorubicin in metastatic breast cancer.
    Sharma S
    J Clin Oncol; 1996 Apr; 14(4):1403. PubMed ID: 8648400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.